Vicapsys Life Sciences annual r&d spending
2019
2020
2021
2022
2023
Vicapsys Life Sciences R&D Spending Growth & History (VICP)
Vicapsys Life Sciences's r&d spending was $15,267 for fiscal 2023.
View full Vicapsys Life Sciences company overviewVicapsys Life Sciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $15,267 | $2,170 | +16.57% |
| 2022 | 2022-12-31 | $13,097 | −$4,601 | −26.00% |
| 2021 | 2021-12-31 | $17,698 | −$84,482 | −82.68% |
| 2020 | 2020-12-31 | $102,180 | $3,197 | +3.23% |
| 2019 | 2019-12-31 | $98,983 | — | — |
Vicapsys Life Sciences quarterly r&d spending
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | $3,746 | $479 | +14.66% |
| Q2 2024 | 2024-06-30 | $10,000 | $8,000 | +400.00% |
| Q1 2024 | 2024-03-31 | $344 | −$9,656 | −96.56% |
| Q4 2023 | 2023-12-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $3,267 | $170 | +5.49% |
| Q2 2023 | 2023-06-30 | $2,000 | $2,000 | — |
| Q1 2023 | 2023-03-31 | $10,000 | $0 | 0.00% |
| Q4 2022 | 2022-12-31 | $0 | −$10,455 | — |
| Q3 2022 | 2022-09-30 | $3,097 | $3,097 | — |
| Q2 2022 | 2022-06-30 | $0 | −$4,936 | — |
| Q1 2022 | 2022-03-31 | $10,000 | $7,693 | +333.46% |
| Q4 2021 | 2021-12-31 | $10,455 | $2,323 | +28.57% |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $4,936 | $4,936 | — |
| Q1 2021 | 2021-03-31 | $2,307 | −$91,741 | −97.55% |
| Q4 2020 | 2020-12-31 | $8,132 | — | — |
| Q3 2020 | 2020-09-30 | $0 | −$98,984 | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
| Q1 2020 | 2020-03-31 | $94,048 | — | — |
| Q3 2019 | 2019-09-30 | $98,984 | — | — |
Vicapsys Life Sciences r&d spending trends
Between the periods ended 2019-12-31 and 2023-12-31, Vicapsys Life Sciences's r&d spending decreased from $98,983 to $15,267, a change of −$83,716. The latest reported quarter, Q3 2024, shows $3,746.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicapsys Life Sciences source filings ↗